[en] BACKGROUND:
The choice of tetanus prophylaxis for patients with wounds depends on obtaining their vaccination history, which has been demonstrated to be unreliable. Use of a rapid immunoassay (Tétanos Quick Stick, the TQS), combined with knowledge of certain demographic characteristics, may improve the evaluation of tetanus immunity and thus help to avoid inadequate prophylactic measures and reduce costs.
OBJECTIVES:
To evaluate the contribution of the TQS in the choice of tetanus prophylaxis and to perform a cost-effectiveness analysis. The final aim was to define the place of the TQS in a modified algorithm for assessment of tetanus immunity in the emergency department.
METHOD:
In this Belgian prospective, double-blind, multicentre study, 611 adult patients with a wound were included; 498 (81.5%) records were valid. The TQS test was performed by a nurse before the vaccination history was taken and the choice of prophylaxis was made, using the official algorithm (Belgian Superior Health Council), by a doctor who was unaware of the TQS result.
RESULTS:
The prevalence of protective anti-tetanus immunity was 74.1%. Immunity was lower in older patients and in female patients. The TQS was a cost-effective tool for patients presenting with a tetanus-prone wound and considered from the vaccination history to be unprotected. Use of the TQS would have improved management in 56.9% (95% CI 47.7% to 65.7%) of patients by avoiding unnecessary treatments, leading to a reduction in the mean cost per patient (10.58 euros/patient with the TQS versus 11.34 euros/patient without). The benefits of the TQS use were significantly greater in patients <61 years old: unnecessary treatment would have been avoided in 76.9% (95% CI 65.8% to 85.4%) of cases and the mean cost per patient reduced to 8.31 euros.
CONCLUSION:
In selected patients, the TQS is a cost-effective tool to evaluate tetanus immunity. An algorithm is proposed for ED assessment of tetanus immunity integrating age and the TQS result.
Disciplines :
Immunology & infectious disease
Author, co-author :
STUBBE, Muriel
MORTELMANS, Luc
DESRUELLE, Didier
SWINNEN, Rohnny
VRANCKX, Marc
BRASSEUR, Edmond ; Centre Hospitalier Universitaire de Liège - CHU > Urgences
LHEUREUX, Philippe
Language :
English
Title :
Improving tetanus prophylaxis in the emergency department: a prospective, double-blind cost-effectiveness study.
Pascual FB, McGinley EL, Zonardi LR, et al. Tetanus surveillance, United States, 1998-2000. MMWR Surveill Summ 2003; 52:1-8.
World Health Organization. Centralized information system for infectious diseases (CISID). http://dato.euro.who.int/cisid (accessed 13 July 2007).
Rushcly AA, White JM, Ramsay ME, et al. Tetanus in England and Wales, 1984-2000. Epidemiol Infect 2003;130:71-7.
Pedalino B, Cotter B, Ciofi degli Atti M, et al. Epidemiology of tetanus in Italy in years 1971-2000. Euro Surveill 2002;7:103-10.
Peetermans WE, Schepens D. Tetanus - still a topic of present interest: a report of 27 cases from a Belgian referral hospital. J Int Medicine 1996;239:249-52.
Hsu S. S, Groleou G. Tetanus in the emergency department: a current review, J Emerg Med 2000;20:357-65.
Sanford JP. Tetanus-forgotten but not gone. N Engl J Med 1995;332:812-13.
Health Council. Advisory reports and recommendations, Federal Public Service, Health, Food Chain Safety and Environment. http://www.health.fgov.be/CSH_HGR/Francais/Brochures/fr2002_tetanos.pdf (accessed 13 July 2007).
Department of Health (UK). Immunisation against infectious disease - "The Green Book". http://www.dh.gov.uk/en/Policyandguidance/ Healthandsocialcaretopics/Greenbook/DH_4097254 (accessed 13 July 2007).
Stubbe M, Swinnen R, Crusiaux A, et al. Seroprotection against tetanus in Patients attending an emergency department in Belgium and evaluation of a bedside immunotest. Eur J Emerg Med 2007; 14:14-24.
Talan DA, Abrahamian FM, Moran GJ, et al. Tetanus immunity and physician compliance with tetanus prophylaxis practices among emergency department patients presenting with wounds. Ann Emerg Med 2004;43:305-14.
Burton T, Crane S. Unnecessary tetanus boosters in the ED. Emerg Med J 2005;22:609-10.
Elkharrat D, Espinoza P, De la Coussaye J, et al. inclusion of a rapid test in the current Health Ministry Guidelines with the purpose of improving anti-tetanus prophylaxiis prescribed to wounded patients presenting at French Emergency Departments. Med Mal Infect 2005;35:323-8.
Ardelean-Jaby D, Kaddari-Himeur F, Nkana-Tameze K, et al. Evaluation of blood test the TQS (Tetanos Quick Stick) used in emergency units. Immuno-analyse and Biologie Spécialisée 2002; 17:330-5.
McQuillan GM, Kruszon-Moran D, Deforest A, et al. Serologic immunity to diphtheria and tetanus in the United States. Ann Intern Med 2002;136:660-6.
Gergen PJ, McQuillan GM, Kiely M, et al. A population-based serologic survey of immunity tetanus in the United States. N Engl J Med 1995;332:761-6.
Edsall G. Editorial: The inexcusable disease. JAMA 1976; 235:62-3.
Brand DA, Acampora D, Gottlieb LD, et al. Adequacy of antitetanus prophylaxis in six hospital emergency rooms. N Engl J Med 1983;309:636-40.
Quinn EH, McIntyre B Peter. Tetanus in elderly - An important preventable disease in Australia. Vaccine 2007;25:1304-09.
Alagappan K, Rennie W, Kwiatkowski T, et al. Seroprevalence of tetanus antibodies among adults older than 65 years. Ann Emerg Med 1996;28:18-21.
Hainz U, Jenewein B, Asch E, et al. Insufficient protection for healthy elderly adults by tetanus and TBE vaccines. Vaccine 2005;23:3232-5.
Edsall G, Elliott MW, Peebles TC, et al. Excessive use of tetanus boosters. JAMA 1967;202:111-13.
Levine L, Edsall G. Tetanus toxoid: what determine reaction proneness? J Infect Dis 1981;144:376.
Creange A, Gray F, Cesaro P, et al. Pooled plasma derivatives and Creutzfeldt-Jakob disease. Lancet 1996; 347:482.